ROCKAWAY, N.J., March 03, 2022 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that it will report financial results for the fourth quarter and year ended December 31, 2021, after the close of the market on Thursday, March 10, 2022. Management will host a conference call and webcast at 4:30 PM Eastern Standard Time to discuss the financial results and answer questions.

Thursday, March 10, 2022, 4:30 PM Eastern Standard Time



Domestic: 877-269-7756

International: 201-689-7817

Conference ID: 13726544

Webcast:


electroCore Earnings Webcast

About electroCore, Inc.


electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company’s current indications are the preventive treatment of cluster headache and migraine, the acute treatment of migraine and episodic cluster headache, the acute and preventive treatment of migraines in adolescents, and paroxysmal hemicrania and hemicrania continua in adults.

For more information, visit


www.electrocore.com


.

Investors:


Rich Cockrell

CG Capital

404-736-3838



[email protected]



or


Media Contact:


Jackie Dorsky

electroCore

908-313-6331



[email protected]